These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
687 related items for PubMed ID: 17692724
1. Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers. Wang Z, Grasela DM, Krishna G. Clin Ther; 2007 Jun; 29(6):1098-106. PubMed ID: 17692724 [Abstract] [Full Text] [Related]
2. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study. Hulhoven R, Rosillon D, Bridson WE, Meeus MA, Salas E, Stockis A. Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264 [Abstract] [Full Text] [Related]
3. Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers. Hofmann C, Banken L, Hahn M, Swearingen D, Nagel S, Martin-Facklam M. Clin Ther; 2012 Oct; 34(10):2061-71. PubMed ID: 22980315 [Abstract] [Full Text] [Related]
4. Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects. Lim KS, Jang IJ, Kim BH, Kim J, Jeon JY, Tae YM, Yi S, Eum S, Cho JY, Shin SG, Yu KS. Clin Ther; 2010 Apr; 32(4):659-66. PubMed ID: 20435235 [Abstract] [Full Text] [Related]
9. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials. Yang H, Laurenza A, Williams B, Patten A, Hussein Z, Ferry J. Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895 [Abstract] [Full Text] [Related]
13. Effects of aliskiren, a direct Renin inhibitor, on cardiac repolarization and conduction in healthy subjects. Ayalasomayajula S, Yeh CM, Vaidyanathan S, Flannery B, Dieterich HA, Howard D, Bedigian MP, Dole WP. J Clin Pharmacol; 2008 Jul; 48(7):799-811. PubMed ID: 18490495 [Abstract] [Full Text] [Related]
15. Etravirine has no effect on QT and corrected QT interval in HIV-negative volunteers. Peeters M, Janssen K, Kakuda TN, Schöller-Gyüre M, Lachaert R, Hoetelmans RM, Woodfall B, De Smedt G. Ann Pharmacother; 2008 Jun; 42(6):757-65. PubMed ID: 18445705 [Abstract] [Full Text] [Related]
18. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings. Noel GJ, Goodman DB, Chien S, Solanki B, Padmanabhan M, Natarajan J. J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866 [Abstract] [Full Text] [Related]
19. Garenoxacin pharmacokinetics in subjects with renal impairment. Krishna G, Gajjar D, Swan S, Marbury T, Grasela DM, Wang Z. Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746 [Abstract] [Full Text] [Related]
20. A single-dose, crossover, placebo- and moxifloxacin-controlled study to assess the effects of neratinib (HKI-272) on cardiac repolarization in healthy adult subjects. Hug B, Abbas R, Leister C, Burns J, Sonnichsen D. Clin Cancer Res; 2010 Aug 01; 16(15):4016-23. PubMed ID: 20647478 [Abstract] [Full Text] [Related] Page: [Next] [New Search]